Shiliang Huang

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsBiologically active moleculesMedical virologyMedical infection agents (incl. prions)Chemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 20, 2025
Design and evaluation of an HSP70-targeting PROTAC in synergy with an HSF1 inhibitor for enhanced antitumor activity.

Wei-Hao Huang, Teng-Yu Mao, Guo-Yao Dai

|Jul 12, 2024
Development of Novel N-Acylhydrazone Derivatives with High Anti-obesity Activity and Improved Safety by Exploring the Pharmaceutical Properties of Aldehyde Group.

Zhi Jiang, Yu-Tao Hu, Shi-Yao Guo

|Jul 29, 2023
MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II.

Jie-Bin Ou, Wei-Hao Huang, Xing-Zi Liu

|May 30, 2023
Design and Synthesis of Bouchardatine Derivatives as a Novel AMP-Activated Protein Kinase Activator for the Treatment of Colorectal Cancer.

Yao-Hao Xu, Yu-Tao Hu, Shu-Min Xu

|Nov 26, 2022
IG1, a Mansonone F Analog, Exhibits Antibacterial Activity against Staphylococcus aureus by Potentially Impairing Cell Wall Synthesis and DNA Replication.

Xin Chen, Yueqiao Lin, Qianqian Gao

|Sep 19, 2022
Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective c-MYC Transcription Repressors Targeting the Promoter G-Quadruplex.

Mao-Lin Li, Jing-Mei Yuan, Hao Yuan

Pageof 2

Frequent Collaborators

5 joint publications

Zhi-Shu Huang

5 joint publications

Qingjiang Li

5 joint publications

Jia-Heng Tan

5 joint publications

Shuo-Bin Chen